|
Open label RCT: Placebo or Real effect?
|
6
|
February 5, 2020
|
|
Handling withdrawn study subjects
|
7
|
February 4, 2020
|
|
Empirical Bayes for RCT Interpretarion
|
8
|
January 29, 2020
|
|
Marginal vs conditional (Mixed) models used in Joint model analysis. The SPRINT trial controversy
|
10
|
December 2, 2019
|
|
Language for communicating frequentist results about treatment effects
|
170
|
November 26, 2019
|
|
2019 Nobel Prize in Economic Sciences is about limitations of RCT
|
16
|
November 5, 2019
|
|
Adherence adjustment in randomized trials is possible, here's why
|
5
|
July 9, 2019
|
|
RCT ceiling effects and high drop off rate
|
7
|
October 14, 2019
|
|
How much patient variability is best for a clinical trial?
|
6
|
September 22, 2019
|
|
Deviation in primary endpoint definition
|
13
|
July 26, 2019
|
|
Advice/Opinion on (reviewing - ethics) an RCT analysis plan
|
2
|
June 28, 2019
|
|
Sample size considerations for interaction covariate adjustment
|
12
|
May 3, 2019
|
|
RCT of calcium supplementation to prevent pre-eclampsia. Huge conditional outcomes issue - what's the best analysis?
|
6
|
March 8, 2019
|
|
DSMB Blinding: Yes or No?
|
13
|
January 26, 2019
|
|
Interim Analysis & "Alpha Spending" in RCT's using Bayesian Analyses
|
16
|
January 25, 2019
|
|
Inequality of Variances in an RCT
|
13
|
December 27, 2018
|
|
Should we ignore covariate imbalance and stop presenting a stratified 'table one' for randomized trials?
|
42
|
December 5, 2018
|
|
Advice for Pooling Two RCTs in Studying Risk Factors for Chronic Pain
|
12
|
December 5, 2018
|
|
Can this be a possible statistical solution for a mid-trial realization?
|
9
|
November 22, 2018
|
|
Proposal for a different way to analyze multivariate treatment safety outcomes
|
1
|
November 11, 2018
|
|
Question on modeling repeated outcomes among single patients
|
10
|
November 7, 2018
|
|
Protocol deviation and its impact on stat analysis
|
9
|
October 21, 2018
|
